Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Taro Pharmaceutical Industries Ltd (NYSE:TARO)

129.24
Delayed Data
As of 3:56pm ET
 -2.36 / -1.79%
Today’s Change
122.99
Today|||52-Week Range
157.99
-16.38%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues212.1M258.3M265.1M233.8M
 
 
 
 
 
Cost of Goods Sold37.5M40.6M37.2M47.2M
 
 
 
 
 
Depreciation And Amortization3.9M3.5M3.5M3.7M
 
 
 
 
 
 
Operating ExpensesGross Income170.7M214.2M224.3M182.9M
 
 
 
 
 
General Expenses42.8M40.8M42.5M40.2M
 
 
 
 
 
Research And Development18.7M17.9M19.9M17.9M
 
 
 
 
 
Total Operating Expenses84.1M85.0M83.3M91.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income127.9M173.4M181.8M142.7M
 
 
 
 
 
Extraordinary Credit--27.0K0.000.00
 
 
Extraordinary Charge-2.9M---95.0K-108.0K
 
 
 
 
Other Expenses35.6M24.6M-46.6M-2.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income164.0M201.0M138.0M140.4M
 
 
 
 
 
Income Taxes-30.4M-11.8M-23.0M-30.4M
 
 
 
 
 
Minority Interest-139.0K-98.0K-65.0K-4.0K
 
 
 
 
 
Discontinued Operations-70.0K-101.0K-34.0K-101.0K
 
 
 
 
 
Net Income133.3M189.0M115.0M109.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.8M42.8M42.8M42.4M
 
 
 
 
 
Shares To Calculate EPS Diluted42.8M42.8M42.8M42.4M
 
 
 
 
 
 
Earnings Per ShareEPS$3.11$4.41$2.68$2.59
 
 
 
 
 
EPS Diluted$3.11$4.41$2.68$2.59